Related Experiment Video
Updated: Mar 16, 2026

11:58
A Protocol for Roux-en-Y Gastric Bypass in Rats using Linear Staplers
Published on: August 21, 2021
6.1K
Evaluation of the Association Between Preoperative Clinical Factors and Long-term Weight Loss After Roux-en-Y Gastric
G Craig Wood1, Peter N Benotti1, Clare J Lee2
1Geisinger Obesity Institute, Geisinger Clinic, Danville, Pennsylvania.
JAMA Surgery
|August 18, 2016
Summary
Preoperative insulin use predicted better long-term weight loss after Roux-en-Y gastric bypass (RYGB), while hyperlipidemia, older age, and higher BMI predicted poorer outcomes. This helps identify patients at risk for suboptimal results.
Area of Science:
- Bariatric surgery outcomes
- Clinical factors in weight management
Background:
- Weight loss after bariatric surgery, specifically Roux-en-Y gastric bypass (RYGB), is variable.
- Understanding preoperative factors linked to long-term suboptimal weight loss is crucial for patient selection and management.
Purpose of the Study:
- To investigate the association between preoperative clinical factors and long-term weight loss (7-12 years) following RYGB.
- To identify predictors of successful and unsuccessful long-term weight management after RYGB.
Main Methods:
- Retrospective cohort study of 726 RYGB patients followed for 7-12 years post-surgery.
- Extracted over 200 preoperative clinical factors including demographics, comorbidities, medications, and lab results.
- Analyzed the correlation between preoperative factors and percentage weight loss (%WL) at long-term follow-up.
Main Results:
- Mean long-term %WL was 22.5%.
- Preoperative insulin use, smoking history, and use of ≥12 medications were associated with greater %WL.
- Preoperative hyperlipidemia, older age, and higher BMI were associated with poorer %WL.
Conclusions:
- Few preoperative factors significantly predict long-term weight loss after RYGB.
- Insulin use is a positive predictor, while hyperlipidemia, older age, and higher BMI are negative predictors of long-term %WL.
- Findings aid in identifying RYGB patients at risk for suboptimal long-term outcomes.

